PROCEPT BioRobotics to Present at the 2023 Wells Fargo Healthcare Conference in Boston

Rhea-AI Summary

PROCEPT BioRobotics® (Nasdaq: PRCT) will present at the 2023 Wells Fargo Healthcare Conference in Boston on September 7 at 3:00 p.m. Eastern Time. The presentation will be available via live webcast and archived on the company's website for at least 90 days.

REDWOOD CITY, Calif., Aug. 17, 2023 (GLOBE NEWSWIRE) -- PROCEPT BioRobotics^® (Nasdaq: PRCT) (the “Company”), a surgical robotics company focused on advancing patient care by developing transformative solutions in urology, today announced that members of management will present at the upcoming 2023 Wells Fargo Healthcare Conference in Boston. Management is scheduled to present on Thursday, September 7 at 3:00 p.m. Eastern Time. A live webcast of the event, as well as an archived recording, will be available on the “Investors” section of the company’s website at: https://ir.procept-biorobotics.com. The webcasts will be archived and available for replay for at least 90 days after the event.

About PROCEPT BioRobotics Corporation
PROCEPT BioRobotics is a surgical robotics company focused on advancing patient care by developing transformative solutions in urology. PROCEPT BioRobotics develops, manufactures and sells the AquaBeam Robotic System, an advanced, image-guided, surgical robotic system for use in minimally invasive urologic surgery with an initial focus on treating benign prostatic hyperplasia, or BPH. BPH is the most common prostate disease and impacts approximately 40 million men in the United States. PROCEPT BioRobotics designed Aquablation therapy to deliver effective, safe and durable outcomes for males suffering from lower urinary tract symptoms, or LUTS, due to BPH that are independent of prostate size and shape or surgeon experience. The Company has developed a significant and growing body of clinical evidence, which includes nine clinical studies and over 150 peer-reviewed publications, supporting the benefits and clinical advantages of Aquablation therapy.

Investor Contact:
Matt Bacso, CFA
VP, Investor Relations and Business Operations
m.bacso@procept-biorobotics.com

FAQ

What is the company presenting at the 2023 Wells Fargo Healthcare Conference?

PROCEPT BioRobotics® will be presenting at the conference.

When and where will the presentation take place?

The presentation will take place on Thursday, September 7 at 3:00 p.m. Eastern Time in Boston.

How can investors access the presentation?

Investors can access the live webcast and archived recording on the 'Investors' section of the company's website.

How long will the webcasts be available for replay?

The webcasts will be available for replay for at least 90 days after the event.